Landon Kyle Oetjen, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dermatitis, Atopic | 4 | 2021 | 653 | 1.000 |
Why?
|
| Sensory Receptor Cells | 3 | 2021 | 487 | 0.930 |
Why?
|
| Pruritus | 5 | 2021 | 359 | 0.920 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2023 | 571 | 0.670 |
Why?
|
| Eczema | 1 | 2018 | 229 | 0.520 |
Why?
|
| Nervous System | 1 | 2018 | 553 | 0.500 |
Why?
|
| Basophils | 1 | 2016 | 389 | 0.480 |
Why?
|
| Immune System | 1 | 2018 | 804 | 0.430 |
Why?
|
| Hypersensitivity | 1 | 2018 | 1093 | 0.340 |
Why?
|
| Skin Diseases | 1 | 2017 | 1065 | 0.330 |
Why?
|
| TRPV Cation Channels | 2 | 2018 | 235 | 0.280 |
Why?
|
| Sezary Syndrome | 2 | 2016 | 76 | 0.270 |
Why?
|
| Epidermis | 2 | 2019 | 527 | 0.270 |
Why?
|
| Signal Transduction | 4 | 2021 | 23387 | 0.190 |
Why?
|
| Receptors, Immunologic | 2 | 2016 | 1423 | 0.180 |
Why?
|
| Asthma | 1 | 2018 | 5955 | 0.170 |
Why?
|
| Inflammation | 2 | 2018 | 10578 | 0.170 |
Why?
|
| Receptors, Neuropeptide | 1 | 2019 | 111 | 0.160 |
Why?
|
| Kallikreins | 1 | 2019 | 258 | 0.160 |
Why?
|
| Janus Kinase 1 | 1 | 2017 | 104 | 0.150 |
Why?
|
| Receptors, IgE | 1 | 2019 | 389 | 0.150 |
Why?
|
| Gastrointestinal Motility | 1 | 2018 | 225 | 0.140 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2017 | 104 | 0.140 |
Why?
|
| High Mobility Group Proteins | 1 | 2016 | 187 | 0.140 |
Why?
|
| Interleukin-13 | 1 | 2017 | 389 | 0.130 |
Why?
|
| Ikaros Transcription Factor | 1 | 2016 | 214 | 0.130 |
Why?
|
| Autoimmunity | 1 | 2023 | 1348 | 0.130 |
Why?
|
| Intracellular Space | 1 | 2016 | 212 | 0.130 |
Why?
|
| Interleukin-3 | 1 | 2016 | 441 | 0.130 |
Why?
|
| Ganglia, Spinal | 1 | 2017 | 517 | 0.130 |
Why?
|
| Mycosis Fungoides | 1 | 2016 | 163 | 0.130 |
Why?
|
| Neoplasms | 1 | 2023 | 21596 | 0.120 |
Why?
|
| Extracellular Space | 1 | 2016 | 594 | 0.120 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2018 | 686 | 0.120 |
Why?
|
| Immunoglobulin E | 2 | 2019 | 1460 | 0.120 |
Why?
|
| Interleukin-4 | 1 | 2017 | 1146 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2016 | 4379 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 1 | 2023 | 6171 | 0.120 |
Why?
|
| Skin | 4 | 2021 | 4353 | 0.110 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2018 | 834 | 0.110 |
Why?
|
| Mast Cells | 1 | 2019 | 1544 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 1221 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2018 | 3731 | 0.100 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1038 | 0.100 |
Why?
|
| Central Nervous System | 1 | 2018 | 1354 | 0.090 |
Why?
|
| Colon | 1 | 2018 | 1773 | 0.090 |
Why?
|
| Disease Susceptibility | 1 | 2016 | 1780 | 0.080 |
Why?
|
| Cell Communication | 1 | 2016 | 1619 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 2513 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 21821 | 0.080 |
Why?
|
| Animals | 9 | 2021 | 168561 | 0.080 |
Why?
|
| Skin Neoplasms | 2 | 2016 | 5662 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2018 | 2723 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2016 | 2066 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 4465 | 0.070 |
Why?
|
| Mice | 7 | 2021 | 81045 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 3381 | 0.060 |
Why?
|
| Macrophages | 1 | 2018 | 5655 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2018 | 3076 | 0.060 |
Why?
|
| Humans | 11 | 2023 | 742088 | 0.050 |
Why?
|
| Cytokines | 1 | 2016 | 7317 | 0.050 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 18006 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2019 | 14554 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 12071 | 0.040 |
Why?
|
| Histamine Antagonists | 1 | 2019 | 93 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2016 | 11470 | 0.040 |
Why?
|
| Mutation | 1 | 2023 | 29717 | 0.040 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2018 | 56 | 0.040 |
Why?
|
| Cyclooxygenase 1 | 1 | 2018 | 104 | 0.040 |
Why?
|
| Tryptases | 1 | 2019 | 190 | 0.040 |
Why?
|
| Histamine | 1 | 2019 | 507 | 0.040 |
Why?
|
| Dinoprostone | 1 | 2018 | 600 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 2018 | 598 | 0.030 |
Why?
|
| Serotonin | 1 | 2019 | 1024 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 766 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2018 | 1241 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2016 | 13029 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2016 | 1905 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2019 | 4211 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 9410 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4751 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6756 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2019 | 5095 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5975 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2016 | 5519 | 0.020 |
Why?
|
| Gene Expression | 1 | 2018 | 7790 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 11001 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2018 | 7873 | 0.010 |
Why?
|
| Male | 4 | 2019 | 349538 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 8425 | 0.010 |
Why?
|
| Female | 4 | 2019 | 379592 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 21719 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 213712 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 57683 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 56350 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 85649 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 162944 | 0.000 |
Why?
|
| Middle Aged | 1 | 2019 | 213127 | 0.000 |
Why?
|